Signaling Pathways
-
A3586 MB050321 CitationSummary: GNG inhibitor,special and efficacious
-
A3604 MibefradilTarget: Voltage-gated Calcium Channels (CaV)Summary: Calcium channel blocker
-
A3606 Micafungin sodiumSummary: Inhibitor of β-(1,3)-D-glucan synthesis;fungicide
-
A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: Glucagon receptor/IGF-1R antagonist
-
A3612 MK-0974Target: CGRP receptorsSummary: CGRP receptor antagonist
-
A3617 MK-4827Target: PARPSummary: PARP-1/-2 inhibitor,potent and selective
-
A3626 ML-7 hydrochlorideTarget: Myosin light chain kinases (MLCKs)Summary: Myosin light chain kinase inhibitor
-
A3629 MLN4924 HCl saltTarget: NAESummary: NAE inhibitor
-
A3632 MotesanibTarget: VEGFRSummary: Inhibitor of Flk-1/Flt-4/PDGFR-/c-Kit
-
A3633 MPEP HydrochlorideTarget: Glutamate (Metabotropic) Group I ReceptorsSummary: MGlu5 receptor antagonist